Skip to main content

Jefferies Financial Group Inc.

Position in URGN — UroGen Pharma Ltd.

CIK 96223 NEW YORK, NY

Position in URGN

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$39,549,742
-$11,966,107 QoQ
Shares Held
2,199,652
0.0% QoQ
Ownership
4.51%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in URGN Over Time

Shares Held

Position Value (USD)

Derivatives in URGN

reported options exposure · as of Jun 30, 2025
CallValue
$411,000
CallShares
30,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Jefferies Financial Group Inc. holds $507,430,268 across 85 Biotechnology names. URGN ranks #3 (7.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 URGN
UroGen Pharma Ltd.
This page
2,199,652 $39,549,742

All Filings in URGN

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $39,549,742 2,199,652
2025-12-31 $51,515,849 2,199,652
2025-09-30 $43,883,057 2,199,652
2025-06-30 $411,000 30,000
2025-06-30 $30,135,232 2,199,652
2025-03-31 $9,013,900 815,000
2024-12-31 $10,287,143 965,929
2024-09-30 $12,255,500 965,000
2024-06-30 $16,192,700 965,000
2024-03-31 $12,600,000 840,000